关键词: 糖尿病, 路径干预, 降糖药物, 分析观察, 合理用药

Abstract: ObjectiveAnalysis of hypoglycemic drugs used in our clinic from 2009 to 2011 is discussed after efficient paths intervention therapy for diabetic patients, which can provide references for deceasing the occurrence of diabetic complication, emergency, hospitalization rate and improving rational clinical drug use on diabetic. Methods Statistics and analysis of the cost of antidiabetic drugs, the proportion of antidiabetic drugs, DDDs, DDc and so on in our clinic from 2009 to 2011 are made by the methods of ranking of amount of money and DDD analysis. ResultsThe variety, number and consumption sum of antidiabetic drugs are increasing year by year from 2009 to 2011. Acarbose, 30R insulin and nateglinide rank the first three places in drug consumption sum; acarbose, 30R insulin and gliclazide rank the first three places in DDDs; 30R insulin, Rinsulin and N insulin rank the first three places in daily cost. ConclusionsWe establish observation medical record for 182 patients with diabetes in community. And we make comparison for 178 diabetic patients between before therapy and after therapy. After intervention therapy, Clinical Pharmacology's use rate decrease apparently and medical resources are saved. And also diabetic complication, emergency and hospitalization rate reduce significiantly after intervention therapy. There is significant statistical significance between data before and after intervention therapy. The use of antidiabetic drugs after paths intervention therapy is reasonable in our clinic. Doctor's prescription can fulfill patient's disease treatment, which predicts economic, safety, reasonable and effective in drug use.

Key words: diabetes, path intervention, antidiabetic drugs, analysis and observation, rational use of drugs